Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members

Endocrinology

Volumn 142, Issue 2, 2001, Pages 778-787

  Turgeon, D ^a   Carrier, J S ^a   Levesque E ^a   Hum, D W ^a   Belanger A ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANEDIOL; CATECHOL ESTROGEN; CYCLOHEXIMIDE; ESTROGEN; GLUCURONOSYLTRANSFERASE; ISOENZYME; STEROID;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME LOCALIZATION; ENZYME SUBSTRATE; GENETIC TRANSCRIPTION; GLUCURONIDATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN STABILITY; TISSUE DISTRIBUTION;

EID: 0035103197     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.2.7958     Document Type: Article

References (49)

1. The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens
2. Negative controls of cell proliferation: Human prostate cancer cells and androgens
3. Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (messenger RNA), but down-regulate the prostatic acid phosphatase messenger RNA in the LNCaP cell line
4. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta
5. Intracrinology
6. Molecular endocrinology of hydroxysteroid dehydrogenases
7. Steroid glucuronides: Human circulatory levels and formation by LNCaP cells
8. Regulation of steroid hormone action in target cells by specific hormone-inactivating enzyme
9. UDP-glucuronosyltransferases
10. UDP-glucuronosyltransferases: A family of detoxifying enzymes
11. Steroid UDP-glucuronosyltransferases
12. The UDP glycosyltransferase gene superfamily: Recommended nomenclature update based on evolutionary divergence
13. Gene structure at the human UGT1 locus creates diversity in isozymes structure, substrate specificity, and regulation
14. Characterization of UDP-glucuronosyltransferases active on steroid hormones
15. Cloning and characterization of a novel human olfactory. UDP-glucuronosyltransferase
16. Isolation and characterization of a novel cDNA encoding a human UDP-glucuronosyltransferase active on C19 steroids
17. Isolation and characterization of UGT2B15(Y85): A UDP-glucuronosyltransferase encoded by a polymorphic gene
18. Characterization and substrate specificity of UGT2B4(E458): A UDP-glucuronosyltransferase encoded by a polymorphic gene
19. Isolation and characterization of a human orphan UDP-glucuronosyltransferase, UGT2B11
20. Cloning of a human liver microsomal UDP-glucuronosyltransferase cDNA
21. Cloning and expression of human liver UDP-glucuronosyltransferase in COS-1 cells: 3,4-Catechol estrogens and estriol as primary substrates
22. Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs
23. cDNA cloning and expression of two new members of the human liver UDP-glucuronosyltransferase 2B subfamily
24. Characterization of a cloned human dihydrotestosterone/androstanediol UDP-glucuronosyltransferase and its comparison to other steroid isoforms
25. Isolation and characterization of the human UGT2B15 gene, localized within a cluster of UGT2B genes and pseudogenes on chromosome 4
26. Expression of UDP-glucuronosyltransferases (UGTs) 2B7 and 1A6 in the human brain and identification of 5-hydroxytryptamine as a substrate
27. Regulation and function of family 1 and 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus
28. Structural and functional studies of UDP-glucuronosyltransferases
29. The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y(268) and UGT2B7H(268)
30. Alteration of human UDP-glucuronosyltransferase UGT2B17 regio-specificity by a single amino acid substitution
31. Codon 377 polymorphism of the human type I 3β-hydroxysteroid dehydrogenase/isomerase gene (HS5DB3)
32. Stable expression of two human UDP-glucuronosyltransferase cDNAs in V79 cell cultures
33. Isolation and characterization of a simian UDP-glucuronosyltransferase UGT2B18 active on 3-hydroxyandrogens
34. Expression and characterization of a novel UDP-glucuronosyltransferase, UGT2B9, from cynomolgus monkey
35. Molecular cloning, expression and characterization of a monkey steroid uridine-diphospho-glucuronosyltransferase, UGT2B19, that conjugates testosterone
36. Cloning and Characterization of a simian UDP-glucuronosyltransferase enzyme UGT2B20, a novel C19 steroid-conjugating protein
37. 3′-Azido-3-′-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7)
38. N-glycosylation and residue 96 are involved in the functional properties of UDP-glucuronosyltransferase enzymes
39. Differential regulation of two UDP-glucuronosyltransferases, UGT2B15 and UGT2B17, in human prostate LNCaP cells
40. Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues
41. Expression of the androgen metabolizing enzyme UGT2B15 in adipose tissue and relative expression measurement using a competitive RT-PCR method
42. Two human liver cDNAs encode UDP-glucuronosyltransferases with 2 log differences in activity toward parallel substrates including hydrodeoxycholic acid and certain estrogen derivatives
43. Cloning and substrate specificity of a human phenol UDP-glucuronosyltransferase expressed in COS-7 cells
44. Regulation of steroid glucuronosyltransferase activities and transcripts by androgen in the human prostatic cancer LNCaP cell line
45. Identification and analysis of drug-responsive expression of UDP-glucuronosyltransferase family 1 (UGT1) isozyme in rat hepatic microsomes using anti-peptide antibodies
46. Effect of interleukins on UGT2B15 and UGT2B17 steroid uridine diphosphate-glucuronosyltransferase expression and activity in the LNCaP cell line
47. Effect of fibroblastic growth factors (FGF) on steroid UDP-glucuronosyltransferase expression and activity in the LNCaP cell line